Publications

Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries.

Arch Womens Ment Health
Toh S, Li Q, Cheetham TC, Cooper WO, Davis RL, Dublin S, Hammad TA, Li DK, Pawloski PA, Pinheiro SP, Raebel MA, Scott PE, Smith DH, Bobo WV, Lawrence JM, Dashevsky I, Haffenreffer K, Avalos LA, Andrade SE

Validation of an algorithm to estimate gestational age in electronic health plan databases.

Pharmacoepidemiol Drug Saf
Li Q, Andrade SE, Cooper WO, Davis RL, Dublin S, Hammad TA, Pawloski PA, Pinheiro SP, Raebel MA, Scott PE, Smith DH, Dashevsky I, Haffenreffer K, Johnson KE, Toh S

Prevalence, trends, and patterns of use of antidiabetic medications among pregnant women, 2001-2007.

Obstet Gynecol
Lawrence JM, Andrade SE, Avalos LA, Beaton SJ, Chiu VY, Davis RL, Dublin S, Pawloski PA, Raebel MA, Smith DH, Toh S, Wang JQ, Kaplan S, Amini T, Hampp C, Hammad TA, Scott PE, Cheetham TC,

Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.

Arch. Intern. Med.
Toh S, Reichman ME, Houstoun M, Ross Southworth M, Ding X, Hernandez AF, Levenson M, Li L, McCloskey C, Shoaibi A, Wu E, Zornberg G, Hennessy S

Trends in the use of antiepileptic drugs among pregnant women in the US, 2001-2007: a medication exposure in pregnancy risk evaluation program study.

Paediatr Perinat Epidemiol
Bobo WV, Davis RL, Toh S, Li DK, Andrade SE, Cheetham TC, Pawloski P, Dublin S, Pinheiro S, Hammad T, Scott PE, Epstein RA, Arbogast PG, Morrow JA, Dudley JA, Lawrence JM, Avalos LA, Cooper WO

Medication Exposure in Pregnancy Risk Evaluation Program.

Matern Child Health J
Andrade SE, Davis RL, Cheetham TC, Cooper WO, Li DK, Amini T, Beaton SJ, Dublin S, Hammad TA, Pawloski PA, Raebel MA, Smith DH, Staffa JA, Toh S, Dashevsky I, Haffenreffer K, Lane K, Platt R, Scott PE

Validity of health plan and birth certificate data for pregnancy research.

Pharmacoepidemiol Drug Saf
Andrade SE, Scott PE, Davis RL, Li DK, Getahun D, Cheetham TC, Raebel MA, Toh S, Dublin S, Pawloski PA, Hammad TA, Beaton SJ, Smith DH, Dashevsky I, Haffenreffer K, Cooper WO

Validation of acute myocardial infarction in the Food and Drug Administration's Mini-Sentinel program.

Pharmacoepidemiol Drug Saf
Cutrona SL, Toh S, Iyer A, Foy S, Daniel GW, Nair VP, Ng D, Butler MG, Boudreau D, Forrow S, Goldberg R, Gore J, McManus D, Racoosin JA, Gurwitz JH

Comparative safety of infliximab and etanercept on the risk of serious infections: does the association vary by patient characteristics?

Pharmacoepidemiol Drug Saf
Toh S, Li L, Harrold LR, Bayliss EA, Curtis JR, Liu L, Chen L, Grijalva CG, Herrinton LJ

A protocol for active surveillance of acute myocardial infarction in association with the use of a new antidiabetic pharmaceutical agent.

Pharmacoepidemiol Drug Saf
Fireman B, Toh S, Butler MG, Go AS, Joffe HV, Graham DJ, Nelson JC, Daniel GW, Selby JV

Design considerations in an active medical product safety monitoring system.

Pharmacoepidemiol Drug Saf
Gagne JJ, Fireman B, Ryan PB, Maclure M, Gerhard T, Toh S, Rassen JA, Nelson JC, Schneeweiss S

Comparative-effectiveness research in distributed health data networks.

Clin. Pharmacol. Ther.
Toh S, Platt R, Steiner JF, Brown JS

Validation of algorithms to ascertain clinical conditions and medical procedures used during pregnancy.

Pharmacoepidemiol Drug Saf
Andrade SE, Moore Simas TA, Boudreau D, Raebel MA, Toh S, Syat B, Dashevsky I, Platt R

National trends in prescribing antidepressants before and after an FDA advisory on suicidality risk in youths.

Psychiatr Serv
Chen SY, Toh S

Confounding adjustment via a semi-automated high-dimensional propensity score algorithm: an application to electronic medical records.

Pharmacoepidemiol Drug Saf
Toh S, García Rodríguez LA, Hernán MA

Cancer risk associated with insulin glargine among adult type 2 diabetes patients--a nationwide cohort study.

PLoS ONE
Chang CH, Toh S, Lin JW, Chen ST, Kuo CW, Chuang LM, Lai MS

Estimating absolute risks in the presence of nonadherence: an application to a follow-up study with baseline randomization.

Epidemiology
Toh S, Hernández-Díaz S, Logan R, Robins JM, Hernán MA

Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial.

Ann. Intern. Med.
Toh S, Hernández-Díaz S, Logan R, Rossouw JE, Hernán MA

Antidepressant use during pregnancy and the risk of preterm delivery and fetal growth restriction.

J Clin Psychopharmacol
Toh S, Mitchell AA, Louik C, Werler MM, Chambers CD, Hernández-Díaz S

Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study.

BMJ
Hernández-Díaz S, Toh S, Cnattingius S